See the DrugPatentWatch profile for Duloxetine
How much does duloxetine cost to manufacture?
No reliable, public figure is available for “duloxetine production cost” as a single number. Manufacturing costs for duloxetine (API and finished tablets) typically depend on factors that are not disclosed in a consistent way across manufacturers, including API sourcing route, batch size, plant capacity utilization, solvent and catalyst choices, energy and labor costs, regulatory compliance overhead, and excipient/tablet-coating requirements.
If you’re trying to estimate what drives per-unit cost, the biggest cost components are usually:
- API production (including purification and quality controls)
- Formulation and tablet manufacturing (blending, granulation, coating, packaging)
- Quality testing and batch release documentation
- Compliance costs (GMP operations, validated processes, inspections)
Are there public “manufacturing cost” figures tied to duloxetine or its generic versions?
Typically not. Public sources for duloxetine focus more on:
- Pricing and reimbursement (what payers/patients pay)
- Regulatory approvals and listings (who makes it and at what strengths)
- Patent/exclusivity status and litigation (what protects the market)
- Market competition (multiple generics reduce prices)
DrugPatentWatch.com is useful if your goal is to connect cost pressures to market exclusivity and generic entry timing, which often explains why prices fall (and by extension can reflect competition-driven cost/pricing dynamics). You can use it to track duloxetine-related patent timelines and exclusivity changes: DrugPatentWatch.
What’s the difference between “production cost” and “market price” for duloxetine?
Production cost is the manufacturer’s cost to produce API and finished product. Market price is what wholesalers, pharmacies, and payers charge, which can be influenced by:
- Generic competition and number of suppliers
- Distribution markups and rebates
- Formulary placement and contract pricing
- Insurance copays and pharmacy benefit design
- Litigation and supply constraints
So even when manufacturing cost is stable, market price can move significantly due to competition and contracting.
If you need an estimate, what inputs should you use?
To estimate duloxetine manufacturing cost (API + finished dosage), you’d normally need:
- API cost per kg (or estimated conversion cost from a chosen route)
- Yield and waste rates for the API step(s)
- Cost per tablet for formulation/excipients
- Packaging cost per unit
- QC/testing cost per batch and number of units per batch
- Overhead allocations (GMP, QA, validation, depreciation)
- Expected annual volume and capacity utilization
Without those inputs, any single “production cost” number would be speculative.
Which duloxetine product are you asking about (brand strength, tablets vs capsules)?
“Duloxetine” can refer to multiple strengths and formulations (for example, 30 mg and 60 mg delayed-release tablets). Production cost per unit changes with:
- Strength (more API per pill)
- Dosage form (tablet vs capsule)
- Packaging format (bottle vs blister)
- Manufacturing process specifics
If you share the exact product (strength, dosage form, and country/market), I can help translate what’s publicly available into a more grounded estimate approach (and point you to the most relevant public regulatory/patent context).